125 related articles for article (PubMed ID: 19967720)
1. Cyclooxygenase inhibitors: scope of their use and development in cancer chemotherapy.
Khan MN; Lee YS
Med Res Rev; 2011 Mar; 31(2):161-201. PubMed ID: 19967720
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 as a target for anticancer drug development.
Méric JB; Rottey S; Olaussen K; Soria JC; Khayat D; Rixe O; Spano JP
Crit Rev Oncol Hematol; 2006 Jul; 59(1):51-64. PubMed ID: 16531064
[TBL] [Abstract][Full Text] [Related]
3. Anti-metastatic action of non-steroidal anti-inflammatory drugs.
Hung WC
Kaohsiung J Med Sci; 2008 Aug; 24(8):392-7. PubMed ID: 18926952
[TBL] [Abstract][Full Text] [Related]
4. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
Sanborn R; Blanke CD
Semin Oncol; 2005 Feb; 32(1):69-75. PubMed ID: 15726508
[TBL] [Abstract][Full Text] [Related]
6. Role of COX-2 specific inhibitors in oncogenesis.
Gumgumji AA; Dawood T; Parvez T
J Coll Physicians Surg Pak; 2003 Jun; 13(6):361-5. PubMed ID: 12814542
[TBL] [Abstract][Full Text] [Related]
7. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
[TBL] [Abstract][Full Text] [Related]
8. Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancer.
Hahn E; Kraus S; Arber N
Dig Dis; 2010; 28(4-5):585-9. PubMed ID: 21088406
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of selective COX-2 inhibitors.
Capone ML; Tacconelli S; Sciulli MG; Patrignani P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
Pruthi RS; Derksen E; Gaston K
J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
Coruzzi G; Venturi N; Spaggiari S
Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
Pereg D; Lishner M
J Intern Med; 2005 Aug; 258(2):115-23. PubMed ID: 16018788
[TBL] [Abstract][Full Text] [Related]
13. Cancer prevention: a new era beyond cyclooxygenase-2.
Rigas B; Kashfi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):1-8. PubMed ID: 15805430
[TBL] [Abstract][Full Text] [Related]
14. Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale.
Amer M; Bead VR; Bathon J; Blumenthal RS; Edwards DN
Cardiol Rev; 2010; 18(4):204-12. PubMed ID: 20539104
[TBL] [Abstract][Full Text] [Related]
15. Selective cyclooxygenase-2 inhibitors for the treatment of arthritis.
Fung HB; Kirschenbaum HL
Clin Ther; 1999 Jul; 21(7):1131-57. PubMed ID: 10463513
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
Dajani EZ; Islam K
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
[TBL] [Abstract][Full Text] [Related]
17. Development of COX inhibitors in cancer prevention and therapy.
Umar A; Viner JL; Anderson WF; Hawk ET
Am J Clin Oncol; 2003 Aug; 26(4):S48-57. PubMed ID: 12902856
[TBL] [Abstract][Full Text] [Related]
18. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
Geis GS
Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
[TBL] [Abstract][Full Text] [Related]
19. Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer.
Sinicrope FA
Mol Carcinog; 2006 Jun; 45(6):447-54. PubMed ID: 16688727
[TBL] [Abstract][Full Text] [Related]
20. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
Kashfi K; Rigas B
Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
